PHLDA3 is an important downstream mediator of p53 in squamous cell carcinogenesis.

[1]  R. Ohki,et al.  p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis , 2020, International journal of molecular sciences.

[2]  A. Levine p53: 800 million years of evolution and 40 years of discovery , 2020, Nature Reviews Cancer.

[3]  H. Aburatani,et al.  Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain , 2019, Cancer science.

[4]  M. Kojima,et al.  Recommendation of long-term and systemic management according to the risk factors in rectal NETs patients , 2019, Scientific Reports.

[5]  H. Aburatani,et al.  PHLDA1, another PHLDA family protein that inhibits Akt , 2018, Cancer science.

[6]  Y. Sakakibara,et al.  Time-Series Analysis of Tumorigenesis in a Murine Skin Carcinogenesis Model , 2018, Scientific Reports.

[7]  L. Attardi,et al.  Deciphering p53 signaling in tumor suppression. , 2018, Current opinion in cell biology.

[8]  C. Blanpain,et al.  Deciphering the cells of origin of squamous cell carcinomas , 2018, Nature Reviews Cancer.

[9]  S. Sumi,et al.  Pleckstrin homology-like domain family A, member 3 (PHLDA3) deficiency improves islets engraftment through the suppression of hypoxic damage , 2017, PloS one.

[10]  Yusuke Nakamura,et al.  The Transcriptional Landscape of p53 Signalling Pathway , 2017, EBioMedicine.

[11]  R. Yi,et al.  Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition. , 2017, Cell stem cell.

[12]  C. Prives,et al.  Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. , 2017, Cold Spring Harbor perspectives in medicine.

[13]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[14]  H. Aburatani,et al.  Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells , 2016, Cancer science.

[15]  A. Rustgi,et al.  Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. , 2016, Cancer cell.

[16]  D. Lambrechts,et al.  Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma , 2015, Nature Medicine.

[17]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[18]  Curtis R. Pickering,et al.  Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma , 2014, Clinical Cancer Research.

[19]  Y. Sakakibara,et al.  Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis , 2014, PloS one.

[20]  B. Tycko,et al.  PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors , 2014, Proceedings of the National Academy of Sciences.

[21]  Deyou Zheng,et al.  SOX9: a stem cell transcriptional regulator of secreted niche signaling factors , 2014, Genes & development.

[22]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[23]  C. Blanpain,et al.  Identifying the cellular origin of squamous skin tumors , 2011, Proceedings of the National Academy of Sciences.

[24]  W. Lowry,et al.  Defining the origins of Ras/p53-mediated squamous cell carcinoma , 2011, Proceedings of the National Academy of Sciences.

[25]  David Lane,et al.  p53 Research: the past thirty years and the next thirty years. , 2010, Cold Spring Harbor perspectives in biology.

[26]  K. Kiguchi,et al.  Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications , 2009, Nature Protocols.

[27]  Tsutomu Ohta,et al.  PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt , 2009, Cell.

[28]  J. Paramio,et al.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma. , 2009, Cancer research.

[29]  F. Tashiro,et al.  p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis , 2008, Oncogene.

[30]  J. Paramio,et al.  Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. , 2007, Cancer research.

[31]  Y. Taya,et al.  Dissecting functional roles of p53 N‐terminal transactivation domains by microarray expression analysis , 2007, Cancer science.

[32]  Hiroshi Masuya,et al.  Enamelin (Enam) is essential for amelogenesis: ENU-induced mouse mutants as models for different clinical subtypes of human amelogenesis imperfecta (AI). , 2005, Human molecular genetics.

[33]  Andreas Luch,et al.  Nature and nurture – lessons from chemical carcinogenesis , 2005, Nature Reviews Cancer.

[34]  B. Tycko,et al.  Placental overgrowth in mice lacking the imprinted gene Ipl , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T. Taniguchi,et al.  Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 Phase* , 2000, The Journal of Biological Chemistry.

[36]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[37]  L. Donehower,et al.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors , 1993, Cell.

[38]  A. Klein-Szanto,et al.  Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. , 1991, Cancer research.